{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:23:41Z","timestamp":1791217421280,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Emergency Medicine"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.annemergmed.2010.03.032","type":"journal-article","created":{"date-parts":[[2010,5,6]],"date-time":"2010-05-06T08:31:34Z","timestamp":1273134694000},"page":"278-282","source":"Crossref","is-referenced-by-count":131,"title":["Therapeutic Efficacy of Icatibant in Angioedema Induced by Angiotensin-Converting Enzyme Inhibitors: A Case Series"],"prefix":"10.1016","volume":"56","author":[{"given":"Murat","family":"Bas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Greve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Stelter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Bier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas K.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Kojda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annemergmed.2010.03.032_bib1","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(08)61242-8","article-title":"Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial","volume":"372","author":"Yusuf","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.annemergmed.2010.03.032_bib2","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1398-9995.2007.01427.x","article-title":"Non-allergic angioedema","volume":"62","author":"Bas","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.annemergmed.2010.03.032_bib3","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annemergmed.2010.03.032_bib4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-2125.2004.02268.x","article-title":"Increased C-reactive protein in ACE-inhibitor-induced angioedema","volume":"59","author":"Bas","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.annemergmed.2010.03.032_bib5","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(97)09137-X","article-title":"Plasma bradykinin in angio-oedema","volume":"351","author":"Nussberger","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.annemergmed.2010.03.032_bib6","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.jaci.2007.02.012","article-title":"Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (icatibant)","volume":"119","author":"Bork","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.annemergmed.2010.03.032_bib7","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1172\/JCI200214211","article-title":"Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor","volume":"109","author":"Han","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.annemergmed.2010.03.032_bib8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1358\/dnp.2004.17.7.863703","article-title":"Biological effects of C1 inhibitor","volume":"17","author":"Davis","year":"2004","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.annemergmed.2010.03.032_bib9","first-page":"313","article-title":"Mutations in the C1 inhibitor gene that result in hereditary angioneurotic edema","volume":"93","author":"Davis","year":"1993","journal-title":"Behring Inst Mitt"},{"key":"10.1016\/j.annemergmed.2010.03.032_bib10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.transci.2003.08.012","article-title":"The pathogenesis of hereditary angioedema","volume":"29","author":"Davis","year":"2003","journal-title":"Transfus Apher Sci"}],"container-title":["Annals of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064410002799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064410002799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T10:27:17Z","timestamp":1544524037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196064410002799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0196064410002799"],"URL":"https:\/\/doi.org\/10.1016\/j.annemergmed.2010.03.032","relation":{},"ISSN":["0196-0644"],"issn-type":[{"value":"0196-0644","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}